Allotment of scrip shares to

RNS Number : 7909Y
The MedicX Fund Limited
04 January 2011
 



 

 

Press Release

For immediate release                                                                                    

4 January 2011

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Allotment of scrip shares to Chairman

 

 

David Staples (the Company's Chairman) elected to participate in the Company's scrip dividend scheme in respect of the December 2010 dividend for the quarter ended 30 September 2010, and accordingly was allotted 575 new ordinary shares of no par value in the Company (the "Shares").  The Shares were admitted to the Official List of the FSA and to trading on the Main Market of the London Stock Exchange on 31 December 2010 and rank pari passu with the Company's existing ordinary shares.

 

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

 

End

 

For further information please contact:

 

MedicX Group                                                                +44 (0)1483 869 500

Keith Maddin, Chairman

Mike Adams, Managing Director

Mark Osmond, Chief Financial Officer

 

Collins Stewart Europe Limited                                        +44 (0)20 7523 8000

Andrew Zychowski/Lucy Lewis

 

Buchanan Communications                                              +44(0)20 7466 5000

Charles Ryland/Suzanne Brocks

 

MedicX Fund Limited                                                       +44 (0)1481 723 450

David Staples, Chairman

 

 

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

 

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.  

 

 The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBBBDDCGXBGGB
UK 100

Latest directors dealings